Whiteside TL - Search Results

1

Autologous lymphokine-activated killer cell therapy of Epstein-Barr virus-positive and -negative lymphoproliferative disorders arising in organ transplant recipients.

Nalesnik MA, Rao AS, Furukawa H, Pham S, Zeevi A, Fung JJ, Klein G, Gritsch HA, Elder E, Whiteside TL, Starzl TE. Nalesnik MA, et al. Among authors: whiteside tl. Transplantation. 1997 May 15;63(9):1200-5. doi: 10.1097/00007890-199705150-00002. Transplantation. 1997. PMID: 9158009 Clinical Trial.

2

Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma.

Lotze MT, Zeh HJ 3rd, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Lotze MT, et al. Among authors: whiteside tl. J Immunother (1991). 1992 Oct;12(3):212-7. doi: 10.1097/00002371-199210000-00015. J Immunother (1991). 1992. PMID: 1359903

3

Lymphokine-activated killer cell and natural killer cell activities in patients with systemic sclerosis.

Kantor TV, Whiteside TL, Friberg D, Buckingham RB, Medsger TA Jr. Kantor TV, et al. Among authors: whiteside tl. Arthritis Rheum. 1992 Jun;35(6):694-9. doi: 10.1002/art.1780350615. Arthritis Rheum. 1992. PMID: 1376124

4

Role of cytokines in the adoptive immunotherapy of an experimental model of human head and neck cancer by human IL-2-activated natural killer cells.

Rabinowich H, Vitolo D, Altarac S, Herberman RB, Whiteside TL. Rabinowich H, et al. Among authors: whiteside tl. J Immunol. 1992 Jul 1;149(1):340-9. J Immunol. 1992. PMID: 1535088

5

Serial monitoring of immunologic function and phenotype of lymphocytes in the blood of transplanted patients randomized to cyclosporine or FK 506.

Whiteside TL, Wilson J, Bryant J, Zeevi A, Abu el-Magd K, Jain A, Alessiani M, Fung J, Herberman RB, Starzl TE. Whiteside TL, et al. Transplant Proc. 1991 Dec;23(6):3047-51. Transplant Proc. 1991. PMID: 1721356 Free PMC article. Clinical Trial. No abstract available.

6

Generation of adherent lymphokine activated killer (A-LAK) cells from patients with acute myelogenous leukaemia.

Sedlmayr P, Rabinowich H, Winkelstein A, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: whiteside tl. Br J Cancer. 1992 Feb;65(2):222-8. doi: 10.1038/bjc.1992.45. Br J Cancer. 1992. PMID: 1739621 Free PMC article.

7

Depressed ability of patients with melanoma or renal cell carcinoma to generate adherent lymphokine-activated killer cells.

Sedlmayr P, Rabinowich H, Elder EM, Ernstoff MS, Kirkwood JM, Herberman RB, Whiteside TL. Sedlmayr P, et al. Among authors: whiteside tl. J Immunother (1991). 1991 Oct;10(5):336-46. doi: 10.1097/00002371-199110000-00005. J Immunother (1991). 1991. PMID: 1790141

8

Natural killer activity of human liver-derived lymphocytes in various liver diseases.

Hata K, Van Thiel DH, Herberman RB, Whiteside TL. Hata K, et al. Among authors: whiteside tl. Hepatology. 1991 Sep;14(3):495-503. Hepatology. 1991. PMID: 1874494

9

Adhesion characteristics of human interleukin 2-activated natural killer cells.

Melder RJ, Walker E, Herberman RB, Whiteside TL. Melder RJ, et al. Among authors: whiteside tl. Cell Immunol. 1991 Jan;132(1):177-92. doi: 10.1016/0008-8749(91)90017-6. Cell Immunol. 1991. PMID: 1905985

10

Surface characteristics, morphology, and ultrastructure of human adherent lymphokine-activated killer cells.

Melder RJ, Walker ER, Herberman RB, Whiteside TL. Melder RJ, et al. Among authors: whiteside tl. J Leukoc Biol. 1990 Aug;48(2):163-73. doi: 10.1002/jlb.48.2.163. J Leukoc Biol. 1990. PMID: 1973444

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

713 results

Search Page

Filters